Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03838250
What this trial is testing

Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC

Who this might be right for
Alcoholic Liver Cirrhosis
Pharmicell Co., Ltd. 10
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Testing effectiveness (Phase 2)Looking for participantsNCT07764497
What this trial is testing

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverLiver Metastasis Colon CancerLiver Metastases From Colorectal Cancer+1 more
Sunnybrook Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Testing effectiveness (Phase 2)Study completedNCT05003700
What this trial is testing

Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 39
Not applicableUnknownNCT02631564
What this trial is testing

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

Who this might be right for
Colon Cancer Liver Metastasis
Fudan University 200
Not applicableLooking for participantsNCT07466238
What this trial is testing

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Peking University 40
Testing effectiveness (Phase 2)Study completedNCT00004142
What this trial is testing

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center 40
Not applicableUnknownNCT04619966
What this trial is testing

Ultrasound Measurements of Hepatic Vasculatures and Hepatic Doppler Assessment of Healthy Children

Who this might be right for
Portal VeinHepatic VeinsHepatic Artery+1 more
Hong Kong Children's Hospital 300
Not applicableUnknownNCT05788835
What this trial is testing

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

Who this might be right for
HCC
Xuhua Duan 220
Testing effectiveness (Phase 2)Study completedNCT05040438
What this trial is testing

Natural Killer (NK) Cell Therapy in Locally Advanced HCC

Who this might be right for
Locally Advanced Hepatocellular Carcinoma
Vaxcell Bio, Co., Ltd. 17
Not applicableUnknownNCT05889325
What this trial is testing

To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)
Peking University Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Testing effectiveness (Phase 2)UnknownNCT04135690
What this trial is testing

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT07560488
What this trial is testing

Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaConversion Therapy
Tianjin Medical University Cancer Institute and Hospital 43
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Early research (Phase 1)UnknownNCT06283303
What this trial is testing

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 8
Next Page